pI: 7.9419 |
Length (AA): 320 |
MW (Da): 35782 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
109 | 139 | 2mrf (A) | 196 | 226 | 39.00 | 0.077 | 0.42 | 0.5397 | 0.4 |
113 | 199 | 5ywr (B) | 141 | 227 | 60.00 | 0.0000000094 | 1 | 1.1773 | -0.57 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_132411)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_11595 | zrfp1-pending-prov protein |
Caenorhabditis elegans | CELE_Y71F9AL.10 | Protein Y71F9AL.10 |
Dictyostelium discoideum | DDB_G0272202 | C2H2-type zinc finger-containing protein |
Drosophila melanogaster | Dmel_CG14435 | CG14435 gene product from transcript CG14435-RC |
Echinococcus granulosus | EgrG_000626800 | Zinc finger RING type |
Echinococcus multilocularis | EmuJ_000626800 | Zinc finger, RING type |
Homo sapiens | ENSG00000186187 | zinc and ring finger 1, E3 ubiquitin protein ligase |
Homo sapiens | ENSG00000180233 | zinc and ring finger 2, E3 ubiquitin protein ligase |
Loa Loa (eye worm) | LOAG_09553 | hypothetical protein |
Mus musculus | ENSMUSG00000033545 | zinc and ring finger 1 |
Mus musculus | 387524 | zinc and ring finger 2 |
Onchocerca volvulus | OVOC11650 |
|
Schmidtea mediterranea | mk4.000779.02 | RE59544p |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Bos taurus | Carbonic anhydrase 3 | 260 aa | 28.8% | 257 aa | Compounds | References |
Bos taurus | Carbonic anhydrase II | 260 aa | 31.6% | 247 aa | Compounds | References |
Bos taurus | Carbonic anhydrase IV | 312 aa | 23.4% | 252 aa | Compounds | References |
Stylophora pistillata | Carbonic anhydrase | 316 aa | 26.7% | 288 aa | Compounds | References |
Rattus norvegicus | Carbonic anhydrase II | 260 aa | 27.2% | 254 aa | Compounds | References |
Astrosclera willeyana | Astrosclerin-3 | 292 aa | 27.8% | 245 aa | Compounds | References |
Sulfurihydrogenibium sp. (strain YO3AOP1) | Carbonate dehydratase | 246 aa | 27.8% | 245 aa | Compounds | References |
Bos taurus | Carbonic anhydrase | 312 aa | 23.4% | 252 aa | Compounds | References |